TPD52 promotes breast cancer cell migration, invasion and proliferation via activation of the MAPK/ERK signaling pathway
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective
Tumor protein D52 (TPD52) is aberrantly expressed in various malignancies; however, its systematic expression profile, prognostic significance, tumor microenvironment associations, and functional mechanisms in breast cancer remain poorly defined.
Methods
GEO and TCGA breast cancer expression datasets were integrated to identify differentially expressed genes (DEGs). We evaluated the diagnostic performance of TPD52 via protein–protein interaction (PPI) network analysis, GO/KEGG enrichment analysis and eleven machine learning algorithms. Immunohistochemistry verified TPD52 protein expression in clinical specimens, and Kaplan–Meier analysis assessed its prognostic significance. Analysis of single-cell transcriptomic data (GSE176078) revealed the cell-type-specific distribution of TPD52 and its intercellular communication network in the breast cancer microenvironment. Weighted gene co-expression network analysis (WGCNA) explored relationships between TPD52 and tumor microbiome, hypoxia signatures as well as microsatellite instability. Moreover, TPD52 was knocked down by siRNA in MCF7 cells, and its impacts on cell migration, invasion, proliferation and the MAPK/ERK signaling pathway were examined through wound healing, Transwell, CCK-8 and Western blot assays.
Results
TPD52 was significantly overexpressed in breast cancer tissues at both the mRNA and protein levels. A random forest-based diagnostic model demonstrated high accuracy across multiple datasets. Kaplan–Meier analysis revealed that elevated TPD52 expression was associated with longer overall survival in specific subgroups, including the basal-like subtype, invasive lobular carcinoma, and N0/N1 stages. Single-cell analysis showed that TPD52 was predominantly expressed in tumor epithelial cells, which occupied a central position within the intercellular communication network. WGCNA further identified a positive correlation between TPD52 and a hypoxia-associated microbial module, as well as a negative correlation with a microsatellite instability module. In vitro functional assays confirmed that TPD52 knockdown significantly suppressed the migration, invasion, and proliferation of MCF7 cells, and led to reduced p-ERK1/2 protein levels.
Conclusion
TPD52 promotes the malignant phenotypes of breast cancer cells through activation of the MAPK/ERK signaling pathway, yet its prognostic significance is subtype-and microenvironment-dependent. These findings establish TPD52 as both a diagnostically valuable biomarker and a mechanistically defined potential therapeutic target.
